Since miR-16, miR-143 and miR-203 target genes control cell proliferation and the miRNAs exhibit a growth suppressive effect in response to E2, we speculated that these miRNAs may be differentially expressed in ER positive and negative breast tumors, acting as a potential causal link with tumor suppressive effects in breast cancer progression. The gene discussed is ESR1; the disease is breast carcinoma.